BriaCell Therapeutics (BCTX)
Develops HLA-matched cell immunotherapies for metastatic breast cancer and other solid tumors.
$3.57
Pre-market−0.01 (−0.28%)
At close$3.58(−1.38%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions14 holders · as of Mar 31, 2026 | 4.44% | 386.7K shares | |
| Strategic holders1 holder · as of Jan 23, 2026 | 8.24% | 716.7K shares | |
| Otherremainder | 87.32% | 7.60M shares |
8.70M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
14 holders · 386.7K shares · 6 new positions · 7 increased · 3 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Cable Car Capital LLC | 216.8K | 2.49% | +216.8Knew | May 15, 2026 |
| Sabby Management, LLC | 73.9K | 0.85% | +73.9Knew | May 15, 2026 |
| Iridian Asset Management LLC/CT | 65.0K | 0.75% | +65.0Knew | Apr 24, 2026 |
| Luminarx Capital Management LP | 15.0K | 0.17% | +15.0Knew | May 14, 2026 |
| UBS Group AG | 11.5K | 0.13% | +10.9K | May 5, 2026 |
| Morgan Stanley | 3.0K | 0.03% | −480 | May 15, 2026 |
| National Bank of Canada /FI/ | 802 | 0.01% | +802new | May 15, 2026 |
| Federation Des Caisses Desjardins du Quebec | 455 | 0.01% | −750 | May 14, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Plambeck Jeremy Myung Jae | 100.00% | 13G | Oct 10, 2025 ↗ | |
| Citadel Advisors LLC | 9.98% | 716.7K | 13G | Jan 23, 2026 ↗ |
| Heights Capital Management, Inc.incl. CVI Investments, Inc. | 8.50% | 13G | Sep 16, 2024 ↗ | |
| CVI Investments, Inc. | 5.70% | 13G | Jul 22, 2025 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.